Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UNC119B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KHDRBS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KHDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C11orf1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBLN3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DHX38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TECRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC8A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on